Differential Diagnosis for Acute Psychosis

Acute psychosis can have various underlying causes, and a thorough differential diagnosis is essential for appropriate management. Here is a brief overview of some of the possibilities for a patient who presents with auditory hallucinations, neologisms, and odd behavior.

Schizophrenia: This is a primary psychotic disorder characterized by Schneider’s first-rank symptoms, which include auditory hallucinations, thought insertion/withdrawal/interruption, thought broadcasting, and delusions of control. Treatment typically involves antipsychotic medications.

Delirium tremens: This is a severe form of alcohol withdrawal that can cause confusion, agitation, tremors, seizures, and autonomic instability. It usually occurs in people with a history of heavy alcohol use and requires urgent medical attention.

Manic-depressive psychosis (bipolar disorder): This is a mood disorder that can involve episodes of elevated or irritable mood (mania or hypomania) and episodes of depressed mood. Psychotic symptoms may occur during manic or mixed episodes, but not necessarily during depressive episodes.

Amphetamine abuse: Stimulant drugs like amphetamines can induce psychosis, which may resemble schizophrenia or other psychotic disorders. A history of drug use and toxicology screening can help identify this possibility.

Subdural hematoma: This is a type of brain injury that can cause symptoms such as headache, confusion, drowsiness, and focal neurological deficits. It is less likely in the absence of a history of head trauma or abnormal findings on neurological examination, but imaging studies may be needed to rule it out.

In summary, the differential diagnosis for acute psychosis includes various psychiatric and medical conditions that require different approaches to treatment and management. A comprehensive evaluation should consider the patient’s history, symptoms, physical and neurological examination, laboratory tests, and imaging studies as needed.

Different Types of Phobias and Anxiety Disorders

Phobias and anxiety disorders are common mental health conditions that affect many people. Here are some examples of different types of phobias and anxiety disorders:

Gamophobia: This is a specific phobia of getting married. It is commonly seen in patients in committed long-term relationships who are terrified of formalizing the relationship in marriage.

Agoraphobia: This is a fear of being out in public. It is a fear of being in situations where escape might be difficult or that help would not be available in case of any accident.

Algophobia: This is a fear of pain.

Acrophobia: This is a fear of heights.

Generalized Anxiety Disorder: This is a condition where a person experiences excessive and persistent worry and anxiety about everyday situations. However, this disorder is inconsistent with a patient who is outgoing and comfortable in public.

Stopping smoking can increase clozapine levels, while starting or increasing smoking can decrease them. Alcohol binges can also increase levels, while omitting doses can decrease them. Stress and weight gain have minimal effects on clozapine levels. It is important to discuss smoking cessation with a psychiatrist before making any changes.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These medications have the advantage of significantly reducing extrapyramidal side-effects. However, they can also cause adverse effects such as weight gain, hyperprolactinaemia, and in the case of clozapine, agranulocytosis. The Medicines and Healthcare products Regulatory Agency has issued warnings about the increased risk of stroke and venous thromboembolism when antipsychotics are used in elderly patients. Examples of atypical antipsychotics include clozapine, olanzapine, risperidone, quetiapine, amisulpride, and aripiprazole.

Clozapine, one of the first atypical antipsychotics, carries a significant risk of agranulocytosis and requires full blood count monitoring during treatment. Therefore, it should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Adverse effects of clozapine include agranulocytosis, neutropaenia, reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

An obsession is an unwelcome and intrusive thought that causes discomfort. On the other hand, a compulsion is an irrational behavior that a person feels compelled to perform in order to alleviate the anxiety caused by the obsession.

Compulsions can be either mental or physical, such as repeatedly washing one’s hands or checking if a door is locked. In contrast, thought insertion is a symptom of schizophrenia where a person feels that their thoughts are not their own and have been inserted by someone else.

Intrusive thoughts are involuntary and unwelcome thoughts that can be experienced by anyone. However, if they become frequent and distressing, they can develop into obsessions, which are a more severe form of intrusive thoughts. Obsessions, when coupled with compulsions, are a defining feature of obsessive-compulsive disorder (OCD).

Lastly, thought withdrawal is another delusion found in schizophrenia where a person believes that their thoughts have been taken away by an external force.

Obsessive-compulsive disorder (OCD) is characterized by the presence of obsessions and/or compulsions that can cause significant functional impairment and distress. Risk factors include family history, age, pregnancy/postnatal period, and history of abuse, bullying, or neglect. Treatment options include low-intensity psychological treatments, SSRIs, and more intensive CBT (including ERP). Severe cases should be referred to the secondary care mental health team for assessment and may require combined treatment with an SSRI and CBT or clomipramine as an alternative. ERP involves exposing the patient to an anxiety-provoking situation and stopping them from engaging in their usual safety behavior. Treatment with SSRIs should continue for at least 12 months to prevent relapse and allow time for improvement.

Differentiating between Psychiatric Disorders: Pain Disorder, Conversion Disorder, Somatization Disorder, PTSD, and Acute Stress Disorder

When evaluating a patient with unexplained physical symptoms, it is important to consider various psychiatric disorders that may be contributing to their presentation. In this case, the patient’s symptoms do not fit the criteria for somatization disorder, PTSD, or acute stress disorder. However, there are other disorders that should be considered.

Pain disorder is characterized by intense, long-standing pain without a somatic explanation. The patient’s pain is out of proportion to the injury and is not explained by any underlying somatic pathology. This disorder is restricted to physical pain and does not include other somatic complaints.

Conversion disorder, on the other hand, presents as a neurological deficit in the absence of a somatic cause. Patients are usually unconcerned about the symptom, unlike this patient. It usually follows a psychosocial stressor.

Somatization disorder refers to patients with a constellation of physical complaints that are not explained by a somatic process. This would include odd distributions of pain, numbness, GI upset, headache, nausea, vomiting, shortness of breath, palpitations, etc. However, this patient is fixated on a particular disease and does not fit the criteria for somatization.

PTSD presents with persistent re-experiencing of the trauma, nightmares, flashbacks, intense fear, avoidant behaviour and/or increased arousal. Symptoms must persist for at least 1 month and impair his quality of life. There are no clear signs of PTSD in this patient.

Acute stress disorder is an anxiety condition precipitated by an acute stress that resolves within a month. This is well beyond the window for acute stress, and it does not fit the symptomatology of acute stress.

In conclusion, it is important to consider various psychiatric disorders when evaluating a patient with unexplained physical symptoms. By ruling out certain disorders, a proper diagnosis and treatment plan can be established.

Undesirable personality traits that are pervasive are characteristic of personality disorders. These disorders cause long-term difficulties in interpersonal relationships and functioning in society. Diagnosis is only possible once a person’s personality has fully developed and their adaptive behaviours have become fixed, typically after the age of 18. However, borderline personality disorder may be diagnosed earlier if there is sufficient evidence that the patient has undergone puberty.

Personality disorders are a set of personality traits that are maladaptive and interfere with normal functioning in life. It is estimated that around 1 in 20 people have a personality disorder, which are typically categorized into three clusters: Cluster A, which includes Odd or Eccentric disorders such as Paranoid, Schizoid, and Schizotypal; Cluster B, which includes Dramatic, Emotional, or Erratic disorders such as Antisocial, Borderline (Emotionally Unstable), Histrionic, and Narcissistic; and Cluster C, which includes Anxious and Fearful disorders such as Obsessive-Compulsive, Avoidant, and Dependent.

Paranoid individuals exhibit hypersensitivity and an unforgiving attitude when insulted, a reluctance to confide in others, and a preoccupation with conspiratorial beliefs and hidden meanings. Schizoid individuals show indifference to praise and criticism, a preference for solitary activities, and emotional coldness. Schizotypal individuals exhibit odd beliefs and magical thinking, unusual perceptual disturbances, and inappropriate affect. Antisocial individuals fail to conform to social norms, deceive others, and exhibit impulsiveness, irritability, and aggressiveness. Borderline individuals exhibit unstable interpersonal relationships, impulsivity, and affective instability. Histrionic individuals exhibit inappropriate sexual seductiveness, a need to be the center of attention, and self-dramatization. Narcissistic individuals exhibit a grandiose sense of self-importance, lack of empathy, and excessive need for admiration. Obsessive-compulsive individuals are occupied with details, rules, and organization to the point of hampering completion of tasks. Avoidant individuals avoid interpersonal contact due to fears of criticism or rejection, while dependent individuals have difficulty making decisions without excessive reassurance from others.

Personality disorders are difficult to treat, but a number of approaches have been shown to help patients, including psychological therapies such as dialectical behavior therapy and treatment of any coexisting psychiatric conditions.

Importance of Mental Health Liaison Team Review Prior to Discharge for Paracetamol Overdose Patients

Paracetamol overdose is a common presentation of self-harm in emergency departments. While medical management is crucial, patients may also require mental health support. A hospital-based mental health liaison team can provide advice on discharge and arrange follow-up if necessary. Discharging a patient without follow-up increases the risk of further self-harm. However, temporary compulsory detention under the Mental Health Act is not appropriate for low-risk patients. Prescribing N-acetyl-L-cysteine is unnecessary if the paracetamol levels are below treatment threshold. Emergency admission to an inpatient psychiatric unit is only necessary for high-risk patients. Therefore, mental health liaison team review prior to discharge is crucial for appropriate management of paracetamol overdose patients.

Understanding Different Types of Depression and Psychotic Disorders

Depression and psychotic disorders can be complex and difficult to diagnose. One condition that can be particularly challenging to identify is schizoaffective disorder, which involves both mood and psychotic symptoms. In some cases, people with schizophrenia may also experience depressive symptoms, but sub-threshold levels of depression are considered a part of the primary disorder.

A major depressive episode is characterized by mood symptoms that last for at least two weeks, along with changes in sleep, appetite, energy, and other neurovegetative functions. Depression can also involve feelings of guilt, worthlessness, and thoughts of suicide.

Dysthymic disorder is a less severe form of depression that does not involve hallucinations. However, if a person experiences hallucinations only during depressive episodes, they may be diagnosed with a major depressive episode with mood-congruent psychotic features.

If a person experiences hallucinations that are not related to their mood, they may be diagnosed with a major depressive episode with mood-incongruent psychotic features. While the presence of psychotic symptoms does not necessarily mean a person has two separate disorders, it can negatively impact their overall outcome. Understanding the different types of depression and psychotic disorders can help clinicians provide more accurate diagnoses and effective treatments.

Understanding the Diagnostic Criteria for Substance Dependence

Substance dependence, including alcohol dependence, is diagnosed based on a set of criteria. These criteria include a strong desire or compulsion to use the substance, difficulty controlling substance use, physiological withdrawal symptoms when substance use is reduced or stopped, evidence of tolerance, neglect of other interests or activities, and continued substance use despite harmful consequences. It is important to note that the presence of a physiological withdrawal state is a key factor in the diagnosis of substance dependence. However, drinking late at night or avoiding sweet drinks are not indicative of dependence. Understanding these criteria can help in identifying and treating substance dependence.

Patients who are taking a SSRI should not use triptans.

Selective serotonin reuptake inhibitors (SSRIs) are commonly used as the first-line treatment for depression. Citalopram and fluoxetine are the preferred SSRIs, while sertraline is recommended for patients who have had a myocardial infarction. However, caution should be exercised when prescribing SSRIs to children and adolescents. Gastrointestinal symptoms are the most common side-effect, and patients taking SSRIs are at an increased risk of gastrointestinal bleeding. Patients should also be aware of the possibility of increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning regarding the use of citalopram due to its association with dose-dependent QT interval prolongation. As a result, citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose of citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

When initiating antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. Patients under the age of 25 years or at an increased risk of suicide should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse. When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, including mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When considering the use of SSRIs during pregnancy, the benefits and risks should be weighed. Use during the first trimester may increase the risk of congenital heart defects, while use during the third trimester can result in persistent pulmonary hypertension of the newborn. Paroxetine has an increased risk of congenital malformations, particularly in the first trimester.